These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3399831)

  • 21. Prevalence of Campylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms.
    Pettross CW; Appleman MD; Cohen H; Valenzuela JE; Chandrasoma P; Laine LA
    Dig Dis Sci; 1988 Jun; 33(6):649-53. PubMed ID: 3371136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of solon on gastric mucus viscosity, permeability to hydrogen ion, and susceptibility to pepsin.
    Sarosiek J; Bilski J; Tsukada H; Slomiany A; Slomiany BL
    Digestion; 1987; 37(4):238-46. PubMed ID: 2824264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastritis and Campylobacter pylori in healthy, asymptomatic volunteers.
    Barthel JS; Westblom TU; Havey AD; Gonzalez F; Everett ED
    Arch Intern Med; 1988 May; 148(5):1149-51. PubMed ID: 3365082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases.
    Slomiany BL; Piotrowski J; Slomiany A
    Am J Gastroenterol; 1992 May; 87(5):595-9. PubMed ID: 1595646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A method of determining Campylobacter pylori in the gastric mucosa in peptic ulcer and chronic gastritis].
    Grigor'ev PIa; Isakov VA; Rozental' VM; Agrba VZ; Tananaeva IK
    Lab Delo; 1989; (6):52-4. PubMed ID: 2474707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin.
    Peterson WL; Lee E; Feldman M
    Gastroenterology; 1988 Nov; 95(5):1185-97. PubMed ID: 3169487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Campylobacter pylori, mucus, and peptic ulceration. A dynamic interaction.
    Ormand JA; Talley NJ
    J Clin Gastroenterol; 1989 Oct; 11(5):492-5. PubMed ID: 2794427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for proteolytic disruption of gastric mucus coat by Campylobacter pylori.
    Slomiany BL; Sarosiek J; Bilski J; Slomiany A
    S Afr Med J; 1988 Jul; 74 Suppl():40-1. PubMed ID: 3388168
    [No Abstract]   [Full Text] [Related]  

  • 30. Lysolecithin affects the viscosity, permeability, and peptic susceptibility of gastric mucin.
    Slomiany BL; Sarosiek J; Liau YH; Laszewicz W; Slomiany A
    Scand J Gastroenterol; 1986 Nov; 21(9):1073-9. PubMed ID: 3810007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional differences of H+, HCO3-, and CO2 diffusion through native porcine gastroduodenal mucus.
    Tanaka S; Meiselman HH; Engel E; Guth PH; Furukawa O; Wenby RB; Lee J; Kaunitz JD
    Dig Dis Sci; 2002 May; 47(5):967-73. PubMed ID: 12018922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Campylobacter pylori: cause of gastritis and ulcer disease?].
    Gebbers JO; Altermatt HJ; Altorfer J
    Schweiz Med Wochenschr; 1988 Apr; 118(16):577-83. PubMed ID: 3289114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro inhibition of peptic degradation of porcine gastric mucus glycoprotein by sucralfate.
    Slomiany BL; Laszewicz W; Slomiany A
    Scand J Gastroenterol; 1985 Sep; 20(7):857-60. PubMed ID: 3931205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Campylobacter pylori--is there a connection with peptic ulcer?].
    Malfertheiner P; Bode G; Vanek E; Stanescu A; Lutz E; Blessing J; Ditschuneit H
    Dtsch Med Wochenschr; 1987 Mar; 112(13):493-7. PubMed ID: 3829927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid urease test provides specific identification of Campylobacter pylori in antral mucosal biopsies.
    Szeto ML; Pounder RE; Hamilton-Dutoit SJ; Dhillon AP
    Postgrad Med J; 1988 Dec; 64(758):935-6. PubMed ID: 3256808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cagA+ and cagA- strains of Helicobacter pylori on the human gastric mucus layer thickness.
    Al-Marhoon MS; Nunn S; Soames RW
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1246-52. PubMed ID: 16048574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Campylobacter pylori in endoscopic biopsies of the gastric antrum and its association with chronic gastritis].
    Ocaña Andrade E; Espinosa Soberanes JA; Marañón Sepúlveda M; Díaz Oyola M; Yañez Montes C
    Rev Gastroenterol Mex; 1989; 54(4):207-11. PubMed ID: 2616983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 in gastric mucosa of children with Helicobacter pylori gastritis: relation to thickness of mucus gel layer.
    Oderda G; D'Alessandro M; Mariani P; Lionetti P; Bonamico M; Dell'Olio D; Ansaldi N
    J Clin Pathol; 1993 Sep; 46(9):836-9. PubMed ID: 8227435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Campylobacter pylori in chronic gastritis].
    Maaroos KhI
    Ter Arkh; 1989; 61(2):35-7. PubMed ID: 2727918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
    Romano M; Ricci V; Di Popolo A; Sommi P; Del Vecchio Blanco C; Bruni CB; Ventura U; Cover TL; Blaser MJ; Coffey RJ; Zarrilli R
    J Clin Invest; 1998 Apr; 101(8):1604-13. PubMed ID: 9541490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.